# Steroid Treatment for Kidney Disease

> **NCT00065611** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 8 (actual)

## Conditions studied

- Nephrosis
- Focal Lipoid Glomerulosclerosis

## Interventions

- **DRUG:** Oral dexamethasone

## Key facts

- **NCT ID:** NCT00065611
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2011-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065611, "Steroid Treatment for Kidney Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00065611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*